- ConsumersRestores CFPB guidance limiting medical debt collection and consumer reporting practices.
- ConsumersReduces the likelihood that certain medical debts will appear on consumer credit reports.
- Targeted stakeholdersMay decrease collection activity for disputed surprise billing amounts affecting vulnerable patients.
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule…
Referred to the House Committee on Financial Services.
This joint resolution uses the Congressional Review Act (chapter 8, title 5, U.S. Code) to disapprove a rule submitted by the Bureau of Consumer Financial Protection (CFPB) that withdrew Bulletin 2022–01.
If enacted, the resolution would render the CFPB’s withdrawal rule (90 Fed.
Reg. 20084 (May 12, 2025)) void and leave Bulletin 2022–01 (87 Fed.
Narrow administrative target improves clarity, but partisan stakes and Senate procedural barriers make enactment uncertain.
Relative to its intended legislative type, this bill is a narrowly focused Congressional Review Act disapproval that is concise and specific about its immediate legal effect but sparse on fiscal, transitional, and downstream-detailing elements.
Consumer protection vs. regulatory burden on providers
Who stands to gain, and who may push back.
- Targeted stakeholdersIncreases compliance costs for hospitals, providers, and third‑party debt collectors.
- Targeted stakeholdersMay reduce the quantity of medical debt information available for credit underwriting decisions.
- Federal agenciesCreates regulatory uncertainty and could prompt litigation over agency authority and the bulletin.
Why the argument around this bill splits.
Consumer protection vs. regulatory burden on providers
Likely strongly supportive because the resolution preserves CFPB guidance limiting medical-debt reporting and protecting consumers under the No Surprises Act.
Supporters will view nullifying the withdrawal as defending consumer credit scores and enforcement clarity.
They may emphasize the bulletin’s role in preventing unfair billing and collection practices.
Cautiously supportive but pragmatic.
Centrist observers appreciate consumer protections and clarity, yet worry about using the CRA to micromanage agency rulemaking and potential costs to health providers.
They will seek clearer cost-benefit information and narrowly tailored language.
Likely opposed.
Conservatives will view the resolution as preserving an overbroad CFPB guidance that expands federal oversight of medical billing and imposes burdens on providers.
They prefer allowing the CFPB to withdraw the bulletin and favor less federal intervention in private billing practices.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow administrative target improves clarity, but partisan stakes and Senate procedural barriers make enactment uncertain.
- Executive branch position on the underlying rule
- Senate filibuster and 60-vote threshold dynamics
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Consumer protection vs. regulatory burden on providers
Narrow administrative target improves clarity, but partisan stakes and Senate procedural barriers make enactment uncertain.
Relative to its intended legislative type, this bill is a narrowly focused Congressional Review Act disapproval that is concise and specific about its immediate legal effect but sparse on fiscal, transitional, and downs…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.